Castle Biosciences Inc — Cash Flow (NASDAQ:CSTL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 9.87 M-18.98 M-41.66 M-5.63 M64.87 M64.35 M 64.35 M Cash from investing activities -4.75 M-66.66 M-166.54 M-16.18 M-50.14 M-60.37 M -60.37 M Cash from financing activities 305.89 M5.42 M1.51 M-2.3 M6.14 M-6.96 M -6.96 M Free cash flow 5.11 M-22.47 M-47.29 M-19.25 M36.54 M28.33 M 28.33 M

News

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents

United Therapeutics Stock Surges 32% in 6 Months: Here's Why

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Stokes Frank sells Castle Biosciences (CSTL) stock worth $192k

LLY Wins CHMP Nod for Olumiant's Expanded Use in Alopecia Areata

REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria

Canaccord reiterates Castle Biosciences stock rating on Q4 beat